Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
about
Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@en
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@nl
type
label
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@en
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@nl
prefLabel
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@en
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@nl
P2093
P2860
P356
P1433
P1476
Safety, Efficacy, and Tolerabi ...... : What Have We Learned so far?
@en
P2093
Ahmed Abdelmonem
Hany M Dabbous
Hany Sayed
Mahmoud S Elmeteini
Moataz Sayam
Mohamed Bahaa
Mohamed F Abdelghafar
Rasha Refai
P2860
P304
P356
10.5812/HEPATMON.35339
P407
P577
2016-04-30T00:00:00Z